Paper Contents
Abstract
This research paper explores the significant role of Artificial Intelligence (AI) in revolutionizing drug design processes. AIs applications in pharmaceutical research have led to increased efficiency, cost-effectiveness, and improved drug discovery. This paper highlights the legal considerations and challenges associated with implementing AI in drug design. Artificial intelligence is thought to be human-like abilities displayed by machines. Deep neural networks and recurrent networks, as well as other artificial neural networks, are the driving forces in this field. De novo design using artificial intelligence directs the creation of functional new biologically active molecules toward desired qualities. The effectiveness of artificial intelligence in this subject is demonstrated by a number of cases, it is possible to combine drug discovery with synthesis planning and simplicity of synthesis, and in the near future, more and more automated drug discovery by computers is anticipated. Additionally, we offer a way for incorporating different computational tools into the discovery and design of novel drugs.
Copyright
Copyright © 2023 Dnyaneshwar gajanan kavane. This is an open access article distributed under the Creative Commons Attribution License.
